Business Services
ANSTO manufactures and supplies radiopharmaceuticals and delivers services in mining, silicon irradiation and specialised analysis, as well as radiation safety training and services.
Chromium-51Cr Edetate Injection BP
Product Information (PI)
Consumer Medical Information (CMI)
| Product Code | 10038 |
| Indications | Chromium [51Cr] Edetate Injection BP is indicated for the determination of glomerular filtration rate in the assessment of renal function. |
| Appearance | Clear, violet solution contained in a 3mL (nominal) serum vial sealed with a gold cap. The volume is as follows: Material No. 10038: 1mL |
| Radioactive Concentration | 7.2 to 8.8 MBq/mL at time and date of calibration |
| Radioactive Content | 7.2 to 8.8 MBq in 1 mL at Calibration |
| pH | The pH of the solution is between 3.5 - 6.5 |
| Chromium Content | <1.0 mg/mL |
| EDTA Content | <15mg/mL free EDTA |
| Radionuclidic Purity | Only [51Cr] detected. No detectable y emitting impurities |
| Radiochemical Purity | ≥95% chromium [51Cr] edetate. <0.5% uncomplexed chromium-51 |
| Specific Activity | Adjusted to be ~30 GBq Chromium-51 per g Chromium |
| Sterility | Sterile |
| Pyrogens | <175 Eu/mL |
| Calibration | 0900 hours Sydney time on the first day of each calendar month |
| Storage | Ambient |
| Availability | Ex stock |
| Expiry | 31 days from calibration |
| Aust R | 22779
|